Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use NUBEQA safely and effectively. See full prescribing information for NUBEQA. NUBEQA® (darolutamide) tablets, for oral use Initial U.S. Approval: 2019
Medication labelWhy this: Advisory · dailymed-prescription
NUBEQA is indicated for the treatment of adult patients with: non-metastatic castration resistant prostate cancer (nmCRPC) metastatic castration-sensitive prostate cancer (mCSPC) metastatic castration-sensitive prostate cancer (mCSPC) in combination with docetaxel.
- generic_name
- darolutamide
- product_names
- darolutamide
- ndc
- 50419-395, 50419-395-01, 50419-395-72
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en